Published in Am J Respir Crit Care Med on August 02, 2007
Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res (2010) 5.17
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30
Exacerbation rate, health status and mortality in COPD--a review of potential interventions. Int J Chron Obstruct Pulmon Dis (2009) 1.85
Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers. Am J Respir Crit Care Med (2014) 1.77
Neighborhoods and chronic disease onset in later life. Am J Public Health (2010) 1.77
Validity of chronic obstructive pulmonary disease diagnoses in a large administrative database. Can Respir J (2012) 1.39
The role of female hormones on lung function in chronic lung diseases. BMC Womens Health (2011) 1.16
Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis (2014) 1.11
Selective accumulation of langerhans-type dendritic cells in small airways of patients with COPD. Respir Res (2010) 1.01
Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes. Med Clin North Am (2012) 0.98
Activity and intracellular location of estrogen receptors alpha and beta in human bronchial epithelial cells. Mol Cell Endocrinol (2009) 0.96
Associations between symptoms, functioning, and perceptions of mastery with global self-rated health in patients with COPD: a cross-sectional study. Int J Nurs Stud (2007) 0.95
Sexually-dimorphic targeting of functionally-related genes in COPD. BMC Syst Biol (2014) 0.94
Development and validation of a model to predict the 10-year risk of general practitioner-recorded COPD. NPJ Prim Care Respir Med (2014) 0.93
Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulm Med (2009) 0.93
Gender influences Health-Related Quality of Life in IPF. Respir Med (2009) 0.92
Gender differences in outcomes of patients with cystic fibrosis. J Womens Health (Larchmt) (2014) 0.91
Association between prevalence of chronic obstructive pulmonary disease and health-related quality of life, South Carolina, 2011. Prev Chronic Dis (2013) 0.90
TLR2/6 stimulation of the rat lung: effects on lymphocyte subsets, natural killer cells and dendritic cells in different parts of the air-conducting compartments and at different ages. Immunology (2008) 0.89
Natural history of emphysema. Proc Am Thorac Soc (2008) 0.89
Soluble receptor for advanced glycation end-products and progression of airway disease. BMC Pulm Med (2014) 0.89
Association between combined interleukin-6 and C-reactive protein levels and pulmonary function in older women: results from the Women's Health and Aging Studies I and II. J Am Geriatr Soc (2011) 0.88
Smoking decreases the response of human lung macrophages to double-stranded RNA by reducing TLR3 expression. Respir Res (2013) 0.87
Respiratory disease in United States farmers. Occup Environ Med (2014) 0.86
Do females behave differently in COPD exacerbation? Int J Chron Obstruct Pulmon Dis (2015) 0.85
Prospective study of dietary fiber and risk of chronic obstructive pulmonary disease among US women and men. Am J Epidemiol (2010) 0.85
Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J Womens Health (Larchmt) (2012) 0.85
Clinical characteristics and quality of life in women with COPD: an observational study. BMC Womens Health (2014) 0.84
Forecasts of COPD mortality in Australia: 2006-2025. BMC Med Res Methodol (2012) 0.84
Chronic respiratory disease among the elderly in South Africa: any association with proximity to mine dumps? Environ Health (2015) 0.84
Lung function in young adults predicts airflow obstruction 20 years later. Am J Med (2010) 0.84
Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease. J Korean Med Sci (2011) 0.83
Accelerated structural decrements in the aging female rhesus macaque lung compared with males. Am J Physiol Lung Cell Mol Physiol (2012) 0.83
Sex and inflammation in respiratory diseases: a clinical viewpoint. Biol Sex Differ (2013) 0.82
Incorporating and evaluating an integrated gender-specific medicine curriculum: a survey study in Dutch GP training. BMC Med Educ (2009) 0.81
Why do we need a nonhuman primate model of smoking-induced COPD? Am J Pathol (2015) 0.80
Bayesian predictors of very poor health related quality of life and mortality in patients with COPD. BMC Med Inform Decis Mak (2013) 0.80
Light smoking at base-line predicts a higher mortality risk to women than to men; evidence from a cohort with long follow-up. BMC Public Health (2014) 0.80
Effects of puberty on cystic fibrosis related pulmonary exacerbations in women versus men. Pediatr Pulmonol (2013) 0.80
The precarious balance between 'supply' and 'demand' for health care: the increasing global demand for rehabilitation service for individuals living with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2008) 0.80
Glucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal Function. J Immunol (2015) 0.79
Genomics of Chronic Obstructive Pulmonary Disease (COPD); Exploring the SNPs of Protease-Antiprotease Pathway. Curr Genomics (2013) 0.79
The effect of dietary antioxidant on the COPD risk: the community-based KoGES (Ansan-Anseong) cohort. Int J Chron Obstruct Pulmon Dis (2015) 0.79
Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary disease. Int J Cancer (2013) 0.79
Relationships among smoking habits, airflow limitations, and metabolic abnormalities in school workers. PLoS One (2013) 0.79
Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons. AIDS (2016) 0.78
Dietary patterns are associated with lung function among Spanish smokers without respiratory disease. BMC Pulm Med (2016) 0.77
Sex-specific features of emphysema among current and former smokers with COPD. Eur Respir J (2015) 0.76
Gender and prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 0.76
Influence of sex and disease severity on gene expression profiles in individuals with idiopathic pulmonary fibrosis. Int J Mol Epidemiol Genet (2014) 0.76
Gender, Estrogen, and Obliterative Lesions in the Lung. Int J Endocrinol (2017) 0.75
Commentary on gender differences in prevalence, treatment, and quality of life of patients with chronic rhinosinusitis. Allergy Rhinol (Providence) (2015) 0.75
A role of indacaterol in chronic obstructive pulmonary disease management: a turning point or crossroads? J Thorac Dis (2013) 0.75
Preventing COPD exacerbations: new options for a crucial and growing problem. Fed Pract (2014) 0.75
Assessing the effect of culturally specific audiovisual educational interventions on attaining self-management skills for chronic obstructive pulmonary disease in Mandarin- and Cantonese-speaking patients: a randomized controlled trial. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease among Nonsmokers: Fifth Korea National Health and Nutrition Examination Survey (2010-2012). Osong Public Health Res Perspect (2016) 0.75
Pharmacological treatment response according to the severity of symptoms in patients with chronic obstructive pulmonary disease. J Thorac Dis (2015) 0.75
Experience of fatigue, and its relationship to physical capacity and disease severity in men and women with COPD. Int J Chron Obstruct Pulmon Dis (2013) 0.75
Prevalence of chronic obstructive pulmonary disease among US working adults aged 40 to 70 years. National Health Interview Survey data 2004 to 2011. J Occup Environ Med (2014) 0.75
Call to action: improving primary care for women with COPD. NPJ Prim Care Respir Med (2017) 0.75
Different types of housing and respiratory health outcomes. Prev Med Rep (2017) 0.75
Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J (1976) 28.28
The validity of self-reported smoking: a review and meta-analysis. Am J Public Health (1994) 13.69
Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill Summ (2002) 7.07
Global burden of COPD: systematic review and meta-analysis. Eur Respir J (2006) 7.00
Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet (2005) 5.61
Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J (1980) 5.21
Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet (2001) 3.96
Gender differences in health: are things really as simple as they seem? Soc Sci Med (1996) 3.58
Gender differences in airway behaviour over the human life span. Thorax (1999) 3.52
Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med (2000) 3.43
Gender bias in the diagnosis of COPD. Chest (2001) 2.87
Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med (2007) 2.77
Gender and COPD in patients attending a pulmonary clinic. Chest (2005) 2.59
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J (2005) 2.51
The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med (1987) 2.43
Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med (2006) 2.28
Bronchodilator response in the lung health study over 11 yrs. Eur Respir J (2005) 2.26
Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 2.20
Cigarette smoke-induced emphysema: A role for the B cell? Am J Respir Crit Care Med (2006) 2.05
The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med (2007) 2.04
Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med (2006) 1.76
Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.72
The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc (2007) 1.65
Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and Rehabilitation Committee of the Canadian Thoracic Society. Chest (1999) 1.59
Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med (2004) 1.52
Gender differences in pain perception and patterns of cerebral activation during noxious heat stimulation in humans. Pain (1998) 1.45
Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res (2006) 1.44
Gender differences in the management and experience of Chronic Obstructive Pulmonary Disease. Respir Med (2004) 1.37
COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. Chest (2007) 1.35
Changes in smoking status affect women more than men: results of the Lung Health Study. Am J Epidemiol (2003) 1.33
Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med (2004) 1.28
Clinical, radiologic, and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med (2002) 1.27
Effect of inhaled fluticasone propionate on airway responsiveness in treatment-naive individuals--a lesser benefit in females. Eur Respir J (2000) 1.25
The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study. N Z Med J (2001) 1.25
Physician perceptions and management of COPD. Chest (1993) 1.17
Gender associated differences in determinants of quality of life in patients with COPD: a case series study. Health Qual Life Outcomes (2006) 1.12
Chronic obstructive pulmonary disease: are women more susceptible than men? Clin Chest Med (2004) 1.10
Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey. Thorax (2004) 1.09
Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study. Respir Med (2005) 1.07
Gender effect on prognosis of patients receiving long-term home oxygen therapy. The Respiratory Failure Research Group in Japan. Am J Respir Crit Care Med (1995) 1.05
Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting. Intern Med J (2001) 0.97
Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? Proc Am Thorac Soc (2006) 0.92
[Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care]. Arch Bronconeumol (2006) 0.91
Sex, access, and excess. Ann Intern Med (1995) 0.88
Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice. Prim Care Respir J (2004) 0.88
Smoke alarm: a review of the clinical impact of smoking on women. Prim Care Update Ob Gyns (2000) 0.85
Is awareness of bodily change in emotion related to awareness of other bodily processes? J Pers Assess (1991) 0.84
Importance of beta(2)adrenergic receptor genotype, gender and race on albuterol-evoked bronchodilation in asthmatics. Pulm Pharmacol Ther (2000) 0.81
The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med (2003) 32.30
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82
Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med (2012) 6.51
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med (2015) 6.03
Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med (2012) 5.33
International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant (2006) 4.95
Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One (2011) 4.65
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet (2009) 4.40
Mechanisms of pulmonary fibrosis. Annu Rev Med (2004) 4.37
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet (2009) 4.29
Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med (2010) 4.19
The effect of age on the development and outcome of adult sepsis. Crit Care Med (2006) 4.08
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med (2009) 4.05
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med (2012) 3.98
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med (2008) 3.97
An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 3.92
Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med (2006) 3.71
Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med (2004) 2.97
Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med (2012) 2.95
Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). Am J Respir Crit Care Med (2005) 2.86
Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med (2007) 2.77
Spirometry utilization for COPD: how do we measure up? Chest (2007) 2.77
Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med (2003) 2.71
Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med (2012) 2.65
Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med (2003) 2.64
The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med (2009) 2.60
Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg (2006) 2.53
Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty--a BOLD analysis. Thorax (2013) 2.52
Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979- 1996). Crit Care Med (2002) 2.52
Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest (2005) 2.41
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med (2006) 2.37
Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med (2003) 2.35
Do insomnia complaints cause hypertension or cardiovascular disease? J Clin Sleep Med (2007) 2.24
The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med (2006) 2.21
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 2.20
Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2007) 2.19
Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax (2012) 2.15
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med (2003) 2.10
Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. FASEB J (2005) 2.09
Does insomnia kill? Sleep (2005) 2.08
A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD (2012) 2.07
Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs (2004) 2.05
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax (2013) 1.99
Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin Infect Dis (2002) 1.98
Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.98
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med (2007) 1.94
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med (2007) 1.94
Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. Am J Pathol (2005) 1.93
COPD surveillance--United States, 1999-2011. Chest (2013) 1.92
An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med (2007) 1.91
Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.90
The prevention and incidence of asthma and mite allergy (PIAMA) birth cohort study: design and first results. Pediatr Allergy Immunol (2002) 1.88
The epidemiology of sepsis in patients with malignancy. Chest (2006) 1.87
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest (2007) 1.87
A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS One (2011) 1.87
Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study. Thorax (2012) 1.82
CT metrics of airway disease and emphysema in severe COPD. Chest (2009) 1.81
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2014) 1.80
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol (2009) 1.78
Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med (2007) 1.77
International Primary Care Respiratory Group (IPCRG) Guidelines: management of chronic obstructive pulmonary disease (COPD). Prim Care Respir J (2006) 1.74
Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med (2009) 1.70
Recent advances in idiopathic pulmonary fibrosis. Chest (2007) 1.69
Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care (2004) 1.69
Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest (2003) 1.68
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. Am J Respir Crit Care Med (2014) 1.68
Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med (2005) 1.67
Self-reported asthma and health-related quality of life: findings from the behavioral risk factor surveillance system. Chest (2003) 1.67
Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med (2013) 1.66
The National Emphysema Treatment Trial (NETT) Part II: Lessons learned about lung volume reduction surgery. Am J Respir Crit Care Med (2011) 1.64
Racial differences in quality of life in patients with COPD. Chest (2011) 1.64
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.63
Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat Genet (2011) 1.60